A prospective case–cohort analysis of plasma metabolites and breast cancer risk

BACKGROUND: Breast cancer incidence rates have not declined despite an improvement in risk prediction and the identification of modifiable risk factors, suggesting the need to identify novel risk factors and etiological pathways involved in this cancer. Metabolomics has emerged as a promising tool t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Victoria L., Carter, Brian D., Jacobs, Eric J., McCullough, Marjorie L., Teras, Lauren R., Wang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847033/
https://www.ncbi.nlm.nih.gov/pubmed/36650550
http://dx.doi.org/10.1186/s13058-023-01602-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847033/
https://www.ncbi.nlm.nih.gov/pubmed/36650550
http://dx.doi.org/10.1186/s13058-023-01602-x

Ejemplares similares